HALEY PICKETT: Open Payments
NPI 1689453656 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 44 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $864
Food & beverage: $780Education: $84
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 13 | $258 |
| Janssen Biotech, Inc. | 8 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| Gilead Sciences, Inc. | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| Mallinckrodt Hospital Products Inc. | 2 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
Products named: IBSRELA, TREMFYA, ENTYVIO, XIFAXAN, VOQUEZNA, TERLIVAZ, IQIRVO.
Industry payments across TX — which companies pay providers there.
